BVS Q4 2020 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$99M+1.1% YoY

Gross Profit

$73M74.5% margin

Operating Income

$6M6.0% margin

Net Income

$3M2.8% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+14.8%

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$7M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$494M

Total Liabilities

$350M

Stockholders' Equity

$142M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$99M	$98M	+1.1%
Gross Profit	$73M	$73M	+0.1%
Operating Income	$6M	$14M	-56.9%
Net Income	$3M	$6M	-50.8%